Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesCeretas Limited

Ceretas Limited

Healthcare Medical Care Facilities
PortfolioPortfolio WatchlistWatchlist
Company price
0.935 AUD 0.01 ( 1.08%)
Last update at 2026-11-12T04:56:00Z
VOLUME
14606
Market Cap
65.67M

Momentum Score

…

Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions. Ceretas Limited was incorporated in 2024 and is based in Brisbane, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.91
Low
0.94
High
52 Week Price Range
0.43
Low
1.11
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Ceretas Limited (CTS.AU) is limited; the company provides minimal operational disclosure in Australian filings. Its core business and material growth drivers cannot be independently confirmed, though clearer disclosure or identified assets could support investor reappraisal over the long term.

Key investment risks are the lack of transparency, low liquidity and small-cap market volatility, and potential financing and execution risk if material operations exist.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.93
Dividend Yield
-
Revenue TTM
1.24M
Revenue Per Share
0.04
Gross Profit TTM
1.24M
Debt / Equity
-
ROE
-128.34%
Net Debt
-
ROCE
-
Diluted EPS TTM
-0.01

Stock Analysis

View All

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
CTS
Ceretas Limited		 0.01
1.08%		 0.94 - - 52.97 -
RHCPA
Ramsay Health Care Ltd		 0.10
0.09%		 108.10 65.76 - 0.77 -
RHC
Ramsay Health Care Ltd		 -0.65
1.16%		 55.42 41.18 31.85 0.69 2.57
REG
Regis Healthcare Ltd		 0.08
1.58%		 5.13 28.22 28.90 1.14 259.34
RYM
Ryman Healthcare Limited		 -0.01
0.33%		 1.52 - - 1.71 0.70

Profile*

Ceretas Limited

Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions. Ceretas Limited was incorporated in 2024 and is based in Brisbane, Australia.

348 Edward Street, Brisbane, QLD, Australia, 4000

61 7 3543 4424

https://ceretas.com.au

Name Title Year Born
Mr. Sam Wetzler Co-Founder & Non-Executive Director NA
Mr. Vesa Peltonen Chief Technology Officer NA
Dr. Anthony James Keating Executive Director NA
Ms. Nicki Farley B.A., L.L.B. Company Secretary 1976
Dr. Rachel de las Heras Co-Founder, CEO, MD & Executive Director NA
Mr. Al Rey Lunar CPA Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…